CSBR
CSBR
NASDAQ · Life Sciences Tools & Services

Champions Oncology Inc

$6.16
-0.27 (-4.20%)
As of Jun 30, 10:35 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +378.1% upside
Low Target $20.89
Average Target $29.45
High Target $33.06
Current Price $6.16
Current
$6.16
Target
$29.45
$20.89 $29.45 avg $33.06
Scenario Analysis
Bear Case
$20.89
239.1%
Low target
Base Case
$29.45
+378.1%
Avg target
Bull Case
$33.06
+436.7%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$9.63
-36.0% from high
52-Week Low
$5.50
+12.0% from low
Target vs 52W High
$29.45
+205.8% vs high
Next Earnings Report
Jul 16, 2026 · After Market Close
14d
until earnings
EPS Est: $-0.05
Earnings in 14 days. Analyst targets may shift significantly after the report.
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
Strong Buy 34 85% $369.21 -26.4%
DHR
Danaher Corp
Strong Buy 30 90% $158.11 -17.0%
A
Agilent Technologies Inc
Strong Buy 28 79% $64.69 -51.3%
WAT
Waters Corp
Buy 28 57% $189.60 -49.4%
IQV
Iqvia Holdings Inc
Strong Buy 30 80% $82.96 -57.1%
ILMN
Illumina Inc
Buy 28 61% $169.36 -3.7%
MTD
Mettler-Toledo International
Hold 20 50% $170.43 -86.7%
WST
West Pharmaceutical Services
Strong Buy 22 82% $136.24 -62.1%